Marinus Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of MRNS for the last quarter is 8.54 M USD, and it's 6.02% higher compared to the previous quarter. The net income of Q3 24 is -24.23 M USD.